|
| Kellogg Parsons, M.D. |
As a graduate of the 2009 AUA Leadership Program, Parsons was one of only two urologists the Western United States selected for this national training program. His paper, "Alcohol Consumption Is Associated With Decreased Risk of Benign Prostatic Hyperplasia" received second place in the American Urological Association National Clinical Research Contest and will be published later this year in The Journal of Urology.
"Dr. Parsons is a superb surgeon-scientist whose research into the causes, prevention and treatment of prostate cancer will have a profound impact on patient care in the coming years," said Christopher Kane, M.D., FACS, chief of urology at UC San Diego Medical Center. "He is one of the reasons that the urology program at UC San Diego Medical Center is top ranked by US News & World Report."
Parsons' clinical practice focuses on the minimally-invasive treatment of urological malignancies, including prostate, kidney and bladder cancer. He has specialized training in minimally-invasive laparoscopic and robotic surgical techniques designed to reduce pain and speed recovery time. He is currently lead investigator of an NIH-funded pilot study, "The Dietary Intervention for Bladder Cancer Study."
Patients interested in meeting Parsons and a multidisciplinary team of cancer specialists may attend a free community seminar on advances in treating prostate cancer on Thursday, Sept. 17, from 6:30 to 8 p.m. at Moores UCSD Cancer Center. The seminar is offered in recognition of Prostate Cancer Awareness Month. For more information about the seminar, call (800) 926-UCSD.

